Neighborhood disadvantage as a risk factor for pediatric obstructive sleep apnea - 09/08/11
, Amy Storfer-Isser, MS, H. Lester Kirchner, PhD, Lisa Nelson, MPA, Carol L. Rosen, MD, Dennis Drotar, PhD, Susan Redline, MD
Reprint requests: Dr James C. Spilsbury, Mental Health Services, Inc., 3740 Euclid Ave., Cleveland, OH 44115Résumé |
Objective |
Low socioeconomic status (SES) is associated with a range of health outcomes. Our objective was to study the relationship between residence in a neighborhood of severe socioeconomic disadvantage and childhood obstructive sleep apnea (OSA).
Study design |
Cross-sectional analysis of 843 (49% female, 36% African-American) children 8 to 11 years of age from a community-based cohort. Data on neighborhood conditions were obtained from the 2000 US Census. The main outcome measure was OSA, defined as an obstructive apnea hypopnea index >5 events per hour or an obstructive apnea index >1 event per hour.
Results |
Residence in a neighborhood of severe socioeconomic disadvantage was significantly associated with OSA after adjusting for effects of previously established risk factors: premature birth, obesity, and African-American ethnicity (OR = 3.44, 95% CI = 1.53-7.75). Secondary analyses showed that neighborhood disadvantage remained significantly associated with OSA: (1) in the African-American subgroup, after controlling for effects of prematurity and obesity; and (2) after controlling for indicators of household-level SES or other health characteristics.
Conclusions |
Childhood OSA is associated with low SES as measured by an index describing severe neighborhood disadvantage, emphasizing the potential importance of environmental factors, particularly those associated with neighborhood distress, as risk factors for OSA.
Le texte complet de cet article est disponible en PDF.Abbreviations : BMI, CCSHS, OSA, SES
Plan
| Supported by grants R01HL60957, 5T32HD041923, K23HL04426, R01NR02707, R01070916, and M01RR00080 from the National Institutes of Health, Bethesda, Maryland. |
Vol 149 - N° 3
P. 342-347 - septembre 2006 Retour au numéro
Article précédent
- A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: Clinical course and coronary artery outcome
- Yoshinari Inoue, Yasunori Okada, Makoto Shinohara, Tohru Kobayashi, Tomio Kobayashi, Takeshi Tomomasa, Kazuo Takeuchi, Akihiro Morikawa, Gunma Kawasaki Disease Study Group ⁎
- Quality of life and psychological adjustment in children and adolescents with neurofibromatosis type 1
- Anna Graf, Markus A. Landolt, Andrea Capone Mori, Eugen Boltshauser
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?